Julie Schweitzer
Women's Health · Saint Peters, MONPI 1215479134
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 372 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,710 and has fallen 67.9% since, to $549 in 2025. Among women's health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$1K
- AbbVie$1K
- Avion Pharmaceuticals$724
- Evofem Biosciences, Inc.$551
- Novo Nordisk$201
- Exeltis, USA Inc.$147
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 90 | $1,164 |
| AbbVie(2 entities) | 77 | $1,119 |
| Avion Pharmaceuticals | 60 | $724 |
| Evofem Biosciences, Inc. | 29 | $551 |
| Novo Nordisk | 11 | $201 |
| Exeltis, USA Inc. | 7 | $147 |
| Coopersurgical, Inc. | 6 | $146 |
| Mylan Pharmaceuticals Inc. | 8 | $142 |
| Pfizer | 8 | $141 |
| Therapeuticsmd, Inc. | 8 | $122 |
| Myovant Sciences Inc. | 6 | $115 |
| Sage Therapeutics, LLC | 6 | $105 |
| Bayer | 6 | $91 |
| Astellas Pharma US Inc | 4 | $89 |
| Currax Pharmaceuticals LLC | 6 | $85 |
| Agile Therapeutics, Inc. | 6 | $84 |
| Dexcom, Inc. | 4 | $79 |
| Hologic Sales And Service, LLC | 4 | $72 |
| Merck | 5 | $72 |
| Optumhealth Care Solutions, LLC | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Organon | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Aspira Women's Health Inc | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Millicent US Inc | 1 | $17 |
| Minerva Surgical, Inc | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$5,629 in reported general payments places this provider in the 95th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $542 |
Paid to pharmacies, not to this prescriber.
Other women's health in Saint Peters
- Angela WarnerSaint Peters$3K
- Kathryn SimoneBlue Springs$192K
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Karla WilmotIndependence$22K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
- Jeanette ShanholtzerLees Summit$7K
- Kris ScalfSaint Louis$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.